Shilpa Pharma Pvt. Ltd., a leading pharmaceutical CDMO and API manufacturer, has achieved the prestigious EcoVadis Gold Medal in November 2025. This recognition places the company in the top 3% of over 130,000 companies globally assessed, highlighting its strong performance in environmental stewardship, social responsibility, ethical governance, and sustainable sourcing.
Outstanding Performance Across Sustainability Pillars
Shilpa Pharma delivered exceptional scores across all four EcoVadis assessment pillars:
- 🌿 Environment: 85/100
- 👥 Labor & Human Rights: 84/100
- ⚖️ Ethics: 79/100
- 🔗 Sustainable Procurement: 77/100
📊 Overall Score: 82/100
🏅 Global Percentile: 98% (Top 3% Globally)
These results reflect Shilpa Pharma’s holistic approach to sustainability, integrating responsible practices across three manufacturing sites, 100+ R&D staff, and a global customer base of 500+.
The Strategic Partnership Behind the Success
Shilpa Pharma’s achievement was supported by Growlity Pvt. Ltd., a leading ESG and sustainability consulting firm. Growlity provided expert guidance on EcoVadis assessment, ESG strategy, sustainability reporting, and supply chain sustainability, enabling Shilpa Pharma to turn its sustainability vision into measurable outcomes.
Why This Achievement Matters
- ✨ Global Recognition: Positions Shilpa Pharma among the world’s leading sustainable pharmaceutical companies.
- 💡 Strategic Integration: ESG principles embedded into operations, culture, and long-term strategy.
- 🎯 Operational Excellence: High scores reflect robust systems and sustainability maturity.
- 🌏 Stakeholder Confidence: Strengthens trust with regulators, partners, and global customers.
Working with Growlity helped us structure and communicate our sustainability journey effectively. Their expertise ensured that our ESG practices were strategically aligned with our business goals.
Achieving the EcoVadis Gold Medal is a significant milestone for Shilpa Pharma. It affirms our commitment to ethical business practices, environmental stewardship, and social responsibility while delivering high-quality healthcare solutions.
Our collaboration with Growlity helped turn sustainability goals into measurable impact. This recognition reflects the efforts of every team member who integrates ESG into daily operations.
Shilpa Pharma’s achievement of the EcoVadis Gold Medal reflects exceptional leadership commitment, operational excellence, and a genuine understanding that sustainability is a core business imperative. Working with their team has been inspiring — they demonstrated remarkable agility, transparency, and dedication to embedding ESG excellence into their organizational fabric.
Achieving Gold Medal recognition in the EcoVadis assessment is a notable accomplishment. Shilpa Pharma succeeded through strategic clarity, robust systems, and authentic commitment to sustainability values. Their dedication to ESG infrastructure and transparency demonstrates that world-class sustainability performance can be achieved with focus and commitment.
About Shilpa Pharma Pvt. Ltd.
Shilpa Pharma Pvt. Ltd. is a leading pharmaceutical CDMO and API manufacturer established in 1987. With three manufacturing sites and a workforce of 1500+, including 100+ R&D specialists, the company serves 500+ global customers. Shilpa Pharma delivers high-quality products and services across NCE development, clinical supply, commercial manufacturing, and analytical services.
The company’s operations are aligned with USFDA standards, UNGC principles, SDGs, PSCI guidelines, NDC, and Science-Based Targets Initiative (SBTi), reinforcing its commitment to long-term sustainability.
About Growlity Pvt. Ltd.
Growlity Pvt. Ltd. is a leading ESG and sustainability consulting firm helping organizations achieve measurable and credible sustainability outcomes. With expertise in EcoVadis assessments, ESG strategy, sustainability reporting, climate action, and supply chain sustainability, Growlity empowers companies to translate their sustainability vision into actionable performance.